Cutaneous Leishmaniasis in West Africa: the Parasite, Vector and Disease

西非皮肤利什曼病:寄生虫、媒介和疾病

基本信息

项目摘要

DESCRIPTION (provided by applicant): Cutaneous leishmaniasis (CL) has a long history in West Africa, but one of the less recognized parasitic infections in the region. The disease is endemic Saharan desert countries in the North, in Sahelian band from west to East Africa. Currently, there is no vaccine against the diseases. However, studies have consistently shown that sand fly saliva generally enhances infectivity of Leishmania parasites in a naive host while an adaptive immune response to whole saliva or a distinct salivary protein generally protects against both cutaneous and visceral leishmaniasis in rodent models of infection. In the proposed work, 3 sites in West Africa each with distinct epidemiological and ecological environment will be compared with regard to intensity and prevalence of cutaneous leishmania infection, sand fly vector population dynamics, and disease pathogenesis with a focus on parasite and host factors and the immune response to candidate vaccines (sand fly proteins in particular). The hypothesis underlying this proposal is that a combination of parasite, vector, and human exposure to other parasitic infection such as infection with microfilariae determine the immunomodulatory effects of candidate vaccines, specifically sand fly proteins. The proposal seeks to 1] understand the basic epidemiology of cutaneous leishmaniasis and its vector in different foci of West Africa; 2] understand mechanism of resistance/susceptibility to the disease; 3] assess how an active infection with microfilariae alters the human immune response to sand fly salivary proteins and 4] reinforce local research capacity for future vaccine trials. RELEVANCE: This proposal is directly relevant to public health because Leishmaniasis take an enormous toll across the globe. Its goals are to examine the epidemiology, transmission of cutaneous leishmaniasis and a component that has been largely overlooked: the immuno-modulation of sandfly proteins. Project 1: Epidemiology of Cutaneous Leishmaniasis Project Leader: Ousmane Faye, MD, PhD (Description as provided by applicant): Leishmaniasis is a vector-borne disease transmitted to the host via the bite of a Leishmania infected phlebotomine sand fly. Cutaneous leishmaniasis (CL) has a long history in West Africa, but is one of the less recognized parasitic infections in the region. Studies have consistently shown that sand fly saliva generally enhances infectivity of Leishmania parasites in a naive host while an adaptive immune response to whole saliva or a distinct salivary protein generally protects against both cutaneous and visceral leishmaniasis in rodent models of infection. In the proposed work, three sites in West Africa each with distinct epidemiological and ecological environment will be compared with regard to intensity and prevalence of cutaneous leishmania infection, sand fly vector population dynamics, and disease pathogenesis with a focus on parasite and host factors and the immune response to candidate vaccines (sand fly proteins in particular). This project seeks to 1] Determine the prevalence/incidence (of infection and disease) of CL and characterize the Leishmania parasites circulating in Malian and Ghanaian classical and cryptic foci of CL; 2] Correlate specific human immune responses to sand fly salivary proteins with CL outcome. In the Aim 1 we will possibly characterize new species of Leishmania parasites from a site where the infected individuals presented with asymptomatic CL and compare it to a classical CL focus. We will also in Aim 2, for the first time, establish if sand fly salivary cellular immunity can influece the CL outcome in endemic populations. RELEVANCE: This project is at the center of the entire proposal because it will assess the relationship between human exposure to sand fly vector bite (Project 2), the parasite and immune response to sand fly salivary proteins (Project 3) and the disease. Understanding of these relationship is important for vaccine development and field trials of control strategies.
描述(由申请人提供):皮肤利什曼病(CL)在西非有很长的历史,但是该地区知名度不佳的寄生虫感染之一。该疾病是北部地区的地方性撒哈拉沙漠国家,从西到东非。目前,没有针对疾病的疫苗。然而,研究一直表明,沙蝇唾液通常会增强幼稚宿主中利什曼原虫的感染性,而对整个唾液或独特的唾液蛋白的适应性免疫反应通常可以预防啮齿动物感染模型中皮肤和内脏利什曼病。在拟议的工作中,在西非的3个地点将与皮肤利什曼原虫感染的强度和患病率,沙蝇载体种群动态和疾病发病机理相比,将进行不同的流行病学和生态环境,并将重点放在寄生虫和宿主因素和宿主因素以及对候选疫苗的免疫反应(尤其是沙蝇蛋白)上。该提案的基本假设是,寄生虫,载体和人类暴露于其他寄生虫感染(例如用微丝菌感染)确定候选疫苗的免疫调节作用,特别是沙蝇蛋白。该提案寻求1]了解皮肤利什曼病及其在西非不同焦点的载体的基本流行病学; 2]了解抗疾病的抗药性/敏感性的机制; 3]评估微丝菌的主动感染如何改变人类对沙蝇唾液蛋白的免疫反应,4]增强了未来疫苗试验的局部研究能力。 相关性:该提案与公共卫生直接相关,因为利什曼病在全球范围内造成巨大损失。它的目标是检查流行病学,皮肤利什曼病的传播以及在很大程度上被忽略的成分:沙蝇蛋白的免疫调节。 项目1:皮肤利什曼病的流行病学 项目负责人:医学博士Ousmane Faye (申请人提供的描述):利什曼病是一种媒介传播的疾病,该疾病是通过感染的利什曼原虫感染的静脉鼻蝇传播给宿主的。皮肤利什曼病(CL)在西非有悠久的历史,但是该地区知名的寄生虫感染之一。研究一直表明,沙蝇在天真的宿主中通常会增强利什曼原虫的感染性,而对整个唾液的适应性免疫反应或不同唾液蛋白通常可以预防啮齿动物感染模型中的皮肤和内脏利什曼病。在拟议的工作中,将在西非的三个地点与皮肤利什曼原虫感染的强度和患病率,沙蝇载体种群动力学以及疾病发病机理的强度和患病率进行比较,并侧重于寄生虫和宿主因素,以及对候选疫苗的免疫反应(尤其是沙蝇蛋白)。该项目寻求1]确定CL的患病率/发病率(感染和疾病的发生率/发病率),并表征了CL的马利亚和加纳古典和隐性灶中循环的利什曼原虫寄生虫; 2]将特定的人类免疫反应与CL结果相关联。在目标1中,我们可能会从一个寄生虫中表征新的利什曼原虫寄生虫,在该地点被感染的个体出现了无症状的CL并将其与经典的CL焦点进行比较。我们还将在AIM 2中首次确定Sand Fly唾液细胞免疫是否可以影响流行种群的CL结果。 相关性:该项目是整个提案的核心,因为它将评估人类接触沙蝇矢量咬合(项目2),寄生虫和对沙蝇唾液唾液蛋白(项目3)的免疫反应与疾病之间的关系。了解这些关系对于控制策略的疫苗开发和现场试验很重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SEYDOU DOUMBIA其他文献

SEYDOU DOUMBIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SEYDOU DOUMBIA', 18)}}的其他基金

West Africa Center of Excellence for Data Science Research Education
西非数据科学研究教育卓越中心
  • 批准号:
    10713853
  • 财政年份:
    2023
  • 资助金额:
    $ 37万
  • 项目类别:
Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP)
马里-几内亚新发传染病研究培训计划(马里-几内亚EID-RTP)
  • 批准号:
    10610927
  • 财政年份:
    2022
  • 资助金额:
    $ 37万
  • 项目类别:
Mali-Guinea Emerging Infectious Disease Research Training Program (Mali-Guinea EID-RTP)
马里-几内亚新发传染病研究培训计划(马里-几内亚EID-RTP)
  • 批准号:
    10461240
  • 财政年份:
    2022
  • 资助金额:
    $ 37万
  • 项目类别:
Effectiveness of the Diabetes Prevention Program in Urban Bamako, Mali: Small Steps, Big Rewards
马里巴马科市区糖尿病预防计划的有效性:小步骤,大回报
  • 批准号:
    10237393
  • 财政年份:
    2020
  • 资助金额:
    $ 37万
  • 项目类别:
United States-Mali Research Ethics Training Program (US-Mali RETP)
美国-马里研究伦理培训计划(US-马里 RETP)
  • 批准号:
    10528469
  • 财政年份:
    2020
  • 资助金额:
    $ 37万
  • 项目类别:
United States-Mali Research Ethics Training Program (US-Mali RETP)
美国-马里研究伦理培训计划(US-马里 RETP)
  • 批准号:
    10132431
  • 财政年份:
    2020
  • 资助金额:
    $ 37万
  • 项目类别:
United States-Mali Research Ethics Training Program (US-Mali RETP)
美国-马里研究伦理培训计划(US-马里 RETP)
  • 批准号:
    10296676
  • 财政年份:
    2020
  • 资助金额:
    $ 37万
  • 项目类别:
ICEMR Mali- Administrative Core
ICEMR 马里 - 行政核心
  • 批准号:
    10381464
  • 财政年份:
    2017
  • 资助金额:
    $ 37万
  • 项目类别:
ICEMR-Mali : Multidisciplinary research for malaria control and prevention in West Africa
ICEMR-马里:西非疟疾控制和预防的多学科研究
  • 批准号:
    9263338
  • 财政年份:
    2017
  • 资助金额:
    $ 37万
  • 项目类别:
West African Center of Excellence for Global Health Bioinformatics Research Training
西非全球健康生物信息学研究培训卓越中心
  • 批准号:
    9770708
  • 财政年份:
    2017
  • 资助金额:
    $ 37万
  • 项目类别:

相似国自然基金

非洲猪瘟病毒B475L蛋白靶向LMP2抑制抗原递呈的分子机制
  • 批准号:
    32302894
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
非洲猪瘟病毒pS273R通过切割G3BP1调控宿主应激颗粒形成的机制
  • 批准号:
    32302893
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
抗体依赖性增强效应介导非洲猪瘟病毒致病的分子机制
  • 批准号:
    32373024
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
非洲爪蟾IV型干扰素IFN-upsilon在不同发育阶段的抗病毒功能研究
  • 批准号:
    32303043
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Mechanistic characterization of vaginal microbiome-metabolome associations and metabolite-mediated host inflammation
阴道微生物组-代谢组关联和代谢物介导的宿主炎症的机制特征
  • 批准号:
    10663410
  • 财政年份:
    2023
  • 资助金额:
    $ 37万
  • 项目类别:
Screening strategies for sexually transmitted infections in a high HIV incidence setting in South Africa
南非艾滋病毒高发地区的性传播感染筛查策略
  • 批准号:
    10761853
  • 财政年份:
    2023
  • 资助金额:
    $ 37万
  • 项目类别:
Understand and mitigating the influence of extreme weather events on HIV outcomes: A global investigation
了解并减轻极端天气事件对艾滋病毒感染结果的影响:一项全球调查
  • 批准号:
    10762607
  • 财政年份:
    2023
  • 资助金额:
    $ 37万
  • 项目类别:
Genetic and Environmental Influences on Individual Sweet Preference Across Ancestry Groups in the U.S.
遗传和环境对美国不同血统群体个体甜味偏好的影响
  • 批准号:
    10709381
  • 财政年份:
    2023
  • 资助金额:
    $ 37万
  • 项目类别:
Exposure to Mixtures of Emerging Contaminants in the Environment - Are Communities in Uganda at Health Risk?- A Case Study of Mbarara City.
接触环境中新兴污染物的混合物 - 乌干达的社区面临健康风险吗? - 姆巴拉拉市的案例研究。
  • 批准号:
    10732272
  • 财政年份:
    2023
  • 资助金额:
    $ 37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了